Circulación Cerebral y Demencia Senil. Interactions between VaD and AD VaD post-stroke dementia infarcts, white matter lesions (WMLs) vascular risk factors.

Slides:



Advertisements
Similar presentations
Journal Club Article 1 Influence of Education on Subcortical Hyperintensities and Global Cognitive Status in Vascular Dementia.
Advertisements

Vascular cognitive impairment – an overview
APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.
Department of Neurology, Mayo Clinic Arizona
Frontotemporal Dementia
J. Stephen Huff, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Significance of White Matter Hyperintensities in MCI Charles DeCarli University of California at Davis Alzheimer’s Disease Center Imaging of Dementia and.
An Approach to Dementia Lisa B. Caruso, MD, MPH Boston University School of Medicine Copyright Boston University Medical Center.
Using neural networks for differential diagnosis of Alzheimer Disease and Vascular Dementia Author: Elizabeth Gaarcia-Perez, Arturo Violante, Francisco.
GAL-INT-6 The safety and efficacy of galantamine in patients with Vascular dementia or AD with cerebrovascular disease Sean Lilienfeld MD, FCP, MMed Janssen.
Dementia. Definition Loss of function in multiple cognitive abilities Assuming the individual had normal abilities before the onset Many of the 70 recognized.
How Alzheimer’s Disease Differs from Frontal Temporal Lobe Dementia (Pick’s Disease) Josepha A. Cheong, MD University of Florida Departments of Psychiatry.
Small Vessel Diseases of the Brain
Subtype of VaD: SIVD Subcortical Ischemic Vascular Disease Helena Chui, M.D. University of Southern California Rancho Los Amigos National Rehabilitation.
Pr Bruno Dubois Head of the Dementia Research Center (IMMA)
Screening for Stroke and Cognitive Impairment Chapter 2: Background.
Alzheimer’s Disease and Biomarkers John H. Dougherty,Jr.M.D. Medical Director Cole Neuroscience Center.
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
VASCULAR DEMENTIA (VaD) A BRIEF REVIEW WITH SPECIAL EMPHASIS ON CURRENT CLINICAL IMPACT MURRAY FLASTER MD, PhD BARROW NEUROLOGICAL CLINIC.
Mild Cognitive Impairment
Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.
Early Brain Changes of Non-Amyloid Pathways Charles DeCarli, MD Victor and Genevieve Orsi Chair in Alzheimer's Research Director University of California.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
Alzheimer’s Disease  Goals  To understand what dementia is  To explore causes, risk factors, symptoms, and treatments of Alzheimer’s Disease  To better.
How To Grow Your Hippocampus in Three Months Majid Fotuhi, MD PhD Founder and Chief Medical Officer NeurExpand Brain Center Nothing to disclose.
Louis Pasteur The many discoveries and inventions that make the modern world we live in.
Dementia. What is Dementia? Dementia is a gradual decline of mental ability that affects your intellectual and social skills to the point where daily.
How to diagnose dementia? Dr. Sridhar Vaitheswaran 25 th October 2012.
Diagnostic Slide Session Mark Samols 1, Kari-Elise Codispoti 1, Marc Rosenblum 2, Barbara Crain 1 1 Johns Hopkins Hospital, Baltimore MD 2 Memorial.
Brain Atrophy in Type 2 Diabetes Regional distribution and influence on cognition Featured Article: Chris Moran, M.B., B.C.H., Thanh G. Phan, P.H.D., Jian.
Is It Alzheimer’s? The Latest Update on Optimal Evaluation and Treatment of Patients with Memory Loss Majid Fotuhi, MD PhD March 5, 2014.
Peripheral and Central Nervous System Drugs Advisory Committee Meeting - March 14, Issues Related to the Development of Drugs for the Treatment.
Assessment and Diagnosis of Dementia Dr Alison Haddow.
Alabama Brief Cognitive Screener (ABCs)
Background. Vascular Cognitive Impairment Vascular Cognitive Impairment (VCI) includes the cognitive and behavioural disorders associated with cerebrovascular.
Louis Pasteur ( ) By: Areli Valencia. Pasteur.
Behavioral Objectives  To make the student define the stroke.  To make the student learn the types of stroke.  To make the student Know who are the.
Vascular Dementia Factors Influencing Diagnostic Accuracy Ranjan Duara, M.D. Wien Center for Alzheimer’s Disease & Memory Disorders, Miami Beach.
Mariano Musacchio 1 François Sellal 2 Frédéric Blanc 2 Jean-Marc Michel 2 Stephan Kremer 3 Jean-Louis Dietemann 3 1 Department of Neuroradiology - CHG.
Structural and Functional Neuroimaging in the Diagnosis of Dementia John M. Ringman, M.D. Assistant Professor UCLA Department of Neurology.
Symposium Neuroradiologicum Cerebral Amyloid Angiopathy- related inflammation: an emerging disease M. Savoiardo, A. Erbetta, J.C. DiFrancesco, M. Brioschi,
Chapter 24 Cognitive Development in Late Adulthood Michael Hoerger.
Practice of Neuropathology Overview and Selected Cases Marc G. Reyes, M.D.
Sint Lucas-Andreas Hospital, Amsterdam
Types of Dementia Dr Bernie Coope Associate Medical Director/Honorary Senior Lecturer, Worcester University Association for Dementia Studies.
NEUROLOGICALSEQUELAE of DIABETESHYPERTENSION “NEUROLOGICAL SEQUELAE of DIABETES & HYPERTENSION ” 1 Patrick A. GRIFFITH, MD, FAAN Professor Clinical Medicine.
Dementia F.Etessam. MD. Dementia A progressive impairment of cognitive functions occurring in clear consciousness.
The Malfunctioning Mind: Degenerative Diseases of the Brain
In collaboration with:
Evidence of Morphologic Differences in Children with Down Syndrome who Develop Infantile Spasms. Nicholas Phillips1,3 , Asim Choudhri2, James Wheless1,
Common causes of dementia based on age at presentation and rate of progression. “Mixed” refers to combined Alzheimer disease and vascular dementia. Totals.
When Not to Intervene in Acute Stroke or
Poststroke dementia Vikas Dhikav,
Common causes of dementia based on age at presentation and rate of progression. “Mixed” refers to combined Alzheimer disease and vascular dementia. Totals.
Nat. Rev. Neurol. doi: /nrneurol
Figure 2 Patterns of brain atrophy in Alzheimer disease
Coronal (above) and axial (below) views of brain imaging findings in selected young onset dementias (images reproduced by kind permission of Dr Hadi Manji.
A 64-year-old female with progressive parkinsonian syndrome
John F. Crary, MD-PhD Associate Professor
Figure 1 Coronal MRI images showing the evolution of white matter abnormality and atrophy of patient 1 Coronal MRI images showing the evolution of white.
Summer School on Neuroscience & Aging
Chapter 93 Dementias and Related Disorders
Psychiatric and Related Disorders
Rubin Becker MD FRCP© Associate Professor McGill University Medical Consultant Manulife and OptimumRe.
Bri Bronsky, Cristin Adams, and Corinne McGill
The Memory Assessment and Treatment Service (MATS)
Neuroimaging and macroscopic features.
Hypertension and Cerebrovascular Dysfunction
MR scans of brain and spine: (A) sagittal T2 image showing signal change in the posterior spinal cord between C3 and T6. MR scans of brain and spine: (A)
Marked progression of PML documented by serial MR studies
Presentation transcript:

Circulación Cerebral y Demencia Senil

Interactions between VaD and AD VaD post-stroke dementia infarcts, white matter lesions (WMLs) vascular risk factors VaD+AD Source: G Roman San Antonio TX Pure AD Pure VaD “ mixed ”

Iason Pratensis (Jason de Pratis) published in Basle (1549) the first textbook of neurology De Cerebri Morbis It included a chapter on dementia De memoriae detrimento Pestronk A. The first neurology book. De Cerebri Morbis...(1549) by Jason Pratensis. Arch Neurol 1988 Mar;45(3):341-4.

1 st description of post-apoplectic dementia: “Dullness of mind and forgetfulness and then afterwards …a stupidity and foolishness. In many, stupidity has accompanied the palsie or has gone before apoplexy” De Anima Brutorum 1672 Thomas Willis at age 45 (1667) In Willis' time, the word foolishness (stultitia in Latin, from stultus foolish, meaning "to be of unsound mind") was equivalent to dementia

Th. Willis Dementia Post-apoplexy Binswanger, Alzheimer Vascular Dementia Kraepelin Arteriosclerotic Dementia Senile & Presenile AD DSM-I Chronic Brain Syndrome Hachinski Scale Roman Vascular Dementia Erkinjuntti Cortical vs. Subcortical Roman NINDS- AIREN Criteria DSM IV- Executive Dysfunction Katzman: AD is the Main Cause of Atrophy and Dementia DSM-III MID NINDS- ADRDA Criteria for AD VaD VCD VCI AD VaD DEMENTIADEMENTIA Pathological reports of Alzheimer’s disease CADASIL 1 st genetic form of VaD 2012 A BRIEF HISTORY OF DEMENTIA

Cerebral circulation Coronary circulation Source: S Salloway

Professor of Chemistry, Lille Director École Normale Supérieure, Paris Silkworm diseases 19 Oct 1868 First stroke, L hemiplegia (Age 46) Pasteur at his laboratory working on the rabies vaccine (portrait by Edelfelt). LOUIS PASTEUR ( )

Pasteur: Left hemiparesis

Professor of Chemistry, Lille École Normale Supérieure, Paris Silkworm diseases 19 Oct 1868 First stroke, L hemiplegia (Age 46) Studies on fermentation and beer Anthrax, fowl cholera Rabies vaccine Oct nd stroke (Age 65) rd stroke (Age 72) LOUIS PASTEUR ( )

“Common Sense” Reisch Margarita Philosophica (1513)

Snowdon D, et al. JAMA March 12, 1997; 277(10):

Concept-changing factors Progress in the neurosciences Neuroimaging Neuropathology Cerebral Blood Flow Neuropsychology Frontal Lobe Genetics Epidemiology Pharmacology

special article Vascular dementia: Diagnostic criteria for research studies Report of the NINDS-AIREN International Workshop GC Román, TK Tatemichi, T Erkinjuntti, JL Cummings, J Masdeu, JH García, L Amaducci, J-M Orgogozo, A Brun, A Hofman, DM Moody, MD O’Brien, T Yamaguchi, J Grafman, BP Drayer, DA Bennett, M Fisher, J Ogata, E Kokmen, F Bermejo, PA Wolf, PB Gorelick, KL Bick, AK Pajeau, MA Bell, C DeCarli, A Culebras, AD Korczyn, J Bogousslavsky, A Hartmann, and P Scheinberg NEUROLOGY 1993;43:

NINDS-AIREN International Workshop on Vascular Dementia; April 19-21, 1991; NIH Campus, Bethesda, Md NINDS/CSN Workshop Bethesda 2005